<p>Monoclonal antibodies that bind and inhibit biological activities of human FGFR2 are disclosed. The antibodies can be used to treat cell proliferative diseases and disorders, including certain forms of cancer, associated with activation or overexpression of FGFR2.</p>
申请公布号
MX2012013068(A)
申请公布日期
2013.03.05
申请号
MX20120013068
申请日期
2011.05.11
申请人
AVEO PHARMACEUTICALS, INC.
发明人
WEILER, SOLLY;MEETZE, KRISTAN;CHEN, TING;WENG, ZHIGANG;WINSTON, WILLIAM, M., JR.;BAI, AILIN;GYURIS, JENO
